Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

• Main Authors: Francesca Poggio (Author), Matteo Lambertini (Author), Claudia Bighin (Author), Benedetta Conte (Author), Eva Blondeaux (Author), Alessia D'Alonzo (Author), Chiara Dellepiane (Author), Giulia Buzzatti (Author), Chiara Molinelli (Author), Francesco Boccardo (Author), Lucia Del Mastro (Author)
• Formato: Libro
• Publicado: SAGE Publishing, 2019-07-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

The use of chemotherapy in premenopausal cancer patients may lead to chemotherapy-induced premature ovarian failure. Pharmacological temporary ovarian suppression obtained with the gonadotropin-releasing hormone agonist (GnRHa) administered concomitantly with chemotherapy has been investigated as a...